Lupker J H
Sanofi Recherche, Centre de Labège, France.
Dev Biol Stand. 1998;93:61-4.
The presence of residual host cell proteins in protein pharmaceuticals obtained from continuous mammalian cell lines has been a point of concern. Clinical experience with different biopharmaceuticals shows that residual protein in these highly purified products does not represent a danger to the health of the patients.